We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FULC icon
1251
Fulcrum Therapeutics
FULC
$249M
$1K ﹤0.01%
138
GBIO
1252
DELISTED
Generation Bio
GBIO
$1K ﹤0.01%
19
GLUE icon
1253
Monte Rosa Therapeutics
GLUE
$1.86B
$1K ﹤0.01%
136
HUMA icon
1254
Humacyte
HUMA
$173M
$1K ﹤0.01%
301
IPSC icon
1255
Century Therapeutics
IPSC
$373M
$1K ﹤0.01%
159
JANX icon
1256
Janux Therapeutics
JANX
$903M
$1K ﹤0.01%
121
KNSA icon
1257
Kiniksa Pharmaceuticals
KNSA
$6.19B
$1K ﹤0.01%
60
KOD icon
1258
Kodiak Sciences
KOD
$2.46B
$1K ﹤0.01%
151
KPTI icon
1259
Karyopharm Therapeutics
KPTI
$160M
$1K ﹤0.01%
9
KRON
1260
DELISTED
Kronos Bio
KRON
$1K ﹤0.01%
164
KZR
1261
DELISTED
Kezar Life Sciences
KZR
$1K ﹤0.01%
15
LXRX icon
1262
Lexicon Pharmaceuticals
LXRX
$1.03B
$1K ﹤0.01%
434
MCRB icon
1263
Seres Therapeutics
MCRB
$46.7M
$1K ﹤0.01%
16
MGNX icon
1264
MacroGenics
MGNX
$241M
$1K ﹤0.01%
209
MGTX icon
1265
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
130
MRSN
1266
DELISTED
Mersana Therapeutics
MRSN
$1K ﹤0.01%
10
MXCT icon
1267
MaxCyte
MXCT
$114M
$1K ﹤0.01%
293
NAUT icon
1268
Nautilus Biotechnolgy
NAUT
$152M
$1K ﹤0.01%
362
OCUL icon
1269
Ocular Therapeutix
OCUL
$1.83B
$1K ﹤0.01%
262
OMER icon
1270
Omeros
OMER
$800M
$1K ﹤0.01%
214
OPTN
1271
DELISTED
OptiNose
OPTN
$1K ﹤0.01%
+21
New +$772
ORIC icon
1272
Oric Pharmaceuticals
ORIC
$1.23B
$1K ﹤0.01%
135
PAHC icon
1273
Phibro Animal Health
PAHC
$1.47B
$1K ﹤0.01%
38
PGEN icon
1274
Precigen
PGEN
$1.94B
$1K ﹤0.01%
708
PHAT icon
1275
Phathom Pharmaceuticals
PHAT
$933M
$1K ﹤0.01%
92

Similar funds

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.